argenex SE (ARGX) vs Vertex Pharmaceuticals Incorporated (VRTX)
argenex SE and Vertex Pharmaceuticals Incorporated are both Biotechnology companies. Vertex Pharmaceuticals Incorporated is the larger, with a market value of $132.3B against $60.2B — 2.2× the size. Vertex Pharmaceuticals Incorporated trades at the lower P/E: 30.4× against 34.6×. argenex SE grew revenue faster over the last twelve months: 70.6% against 10.2%. Vertex Pharmaceuticals Incorporated has the higher net margin (35.0% vs 32.2%) and the higher return on invested capital (24.1% vs 20.7%). Across the 21 metrics below, Vertex Pharmaceuticals Incorporated leads on 14 and argenex SE on 7.
Valuation
Profitability
| Metric | ARGX | VRTX | Biotechnology median |
|---|---|---|---|
| Gross margin | 90.15% | 86.00% | 65.16% |
| Operating margin | 30.06% | 37.95% | 0.00% |
| Net margin | 32.20% | 35.00% | 0.00% |
| Free cash flow margin | 25.87% | 30.16% | 0.00% |
| Return on equity | 27.07% | 23.54% | (57.72%) |
| Return on assets | 19.95% | 17.12% | (49.22%) |
| Return on invested capital | 20.71% | 24.09% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack